(Q27851665)
Statements
1 reference
Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy (English)
1 reference
October 2011
0 references
10
0 references
10
0 references
1993-9
0 references